We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$7.52B
AUM Growth
+$1.2B
Cap. Flow
+$726M
Cap. Flow %
9.65%
Top 10 Hldgs %
19.11%
Holding
866
New
79
Increased
318
Reduced
279
Closed
56

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$75M
2
BIIB icon
Biogen
BIIB
+$70.7M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$60.1M
4
MRK icon
Merck
MRK
+$54.6M
5
GILD icon
Gilead Sciences
GILD
+$33.1M

Top Sells

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$19.1M
2
IRBT
iRobot
IRBT
+$15.5M
3
DGX icon
Quest Diagnostics
DGX
+$15.4M
4
CL icon
Colgate-Palmolive
CL
+$14.8M
5
PM icon
Philip Morris
PM
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33.26%
2 Technology 16.05%
3 Financials 11.26%
4 Consumer Discretionary 7.98%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KSS icon
526
Kohl's
KSS
$2.1B
$1.66M 0.02%
22,270
-463
-2% -$35K
GT icon
527
Goodyear
GT
$2.04B
$1.66M 0.02%
70,870
-148,928
-68% -$3.5M
PARA
528
DELISTED
Paramount Global Class B
PARA
$1.66M 0.02%
28,836
CP icon
529
Canadian Pacific Kansas City
CP
$81.1B
$1.64M 0.02%
38,830
-1,880
-5% -$75.2K
GPN icon
530
Global Payments
GPN
$22.9B
$1.6M 0.02%
12,588
-5,834
-32% -$702K
HLT icon
531
Hilton Worldwide
HLT
$74.9B
$1.59M 0.02%
19,655
-11,310
-37% -$891K
DGX icon
532
Quest Diagnostics
DGX
$25.5B
$1.58M 0.02%
14,689
-140,052
-91% -$15.4M
ANDV
533
DELISTED
Andeavor
ANDV
$1.58M 0.02%
10,326
-5,543
-35% -$818K
AORT icon
534
Artivion
AORT
$1.27B
$1.58M 0.02%
45,000
DLR icon
535
Digital Realty Trust
DLR
$72B
$1.57M 0.02%
13,948
+948
+7% +$113K
O icon
536
Realty Income
O
$61.4B
$1.54M 0.02%
27,868
+2,452
+10% +$135K
S
537
DELISTED
Sprint Corporation
S
$1.51M 0.02%
230,480
-36,319
-14% -$216K
MKL icon
538
Markel Group
MKL
$25.2B
$1.5M 0.02%
1,262
VTR icon
539
Ventas
VTR
$48.7B
$1.5M 0.02%
27,533
+2,159
+9% +$125K
IDXX icon
540
Idexx Laboratories
IDXX
$43.7B
$1.48M 0.02%
5,924
+289
+5% +$70.2K
DRI icon
541
Darden Restaurants
DRI
$23.3B
$1.48M 0.02%
13,270
+7,475
+129% +$842K
CTAS icon
542
Cintas
CTAS
$84.3B
$1.46M 0.02%
29,472
INSM icon
543
Insmed
INSM
$22.9B
$1.45M 0.02%
70,717
-24,350
-26% -$550K
DLTR icon
544
Dollar Tree
DLTR
$23.8B
$1.45M 0.02%
17,746
-677
-4% -$59.4K
NXEO
545
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$1.43M 0.02%
+116,732
New +$1.17M
EDU icon
546
New Oriental
EDU
$7.94B
$1.41M 0.02%
+19,000
New +$1.58M
GL icon
547
Globe Life
GL
$13.5B
$1.4M 0.02%
16,102
-1,112
-6% -$96.1K
GPC icon
548
Genuine Parts
GPC
$17.6B
$1.38M 0.02%
13,870
-1,198
-8% -$117K
ALLY icon
549
Ally Financial
ALLY
$13.3B
$1.37M 0.02%
51,878
-2,416
-4% -$65.6K
ESS icon
550
Essex Property Trust
ESS
$18.7B
$1.37M 0.02%
5,557

Similar funds

Candriam SCA's Q3 2018 Portfolio in Review

As of Q3 2018, Candriam SCA held 866 positions worth $7.52B, up 19% from $6.32B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Candriam SCA deployed $726M of net new capital in Q3 2018, opening 79 new positions and adding to 318 existing holdings. Its largest new stake was Varonis Systems: 541,092 shares worth $13.2M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $19.1M trimmed.

  • Candriam SCA's largest Q3 2018 buy was Varonis Systems: 541,092 shares worth $13.2M.
  • Candriam SCA added most to Amgen in Q3 2018, an estimated $75M increase.
  • Candriam SCA's biggest Q3 2018 reduction was Advanced Micro Devices, cutting an estimated $19.1M.
  • Candriam SCA fully exited iRobot in Q3 2018, selling an estimated $15.5M.
  • Candriam SCA's ten largest holdings make up 19% of its $7.52B portfolio in Q3 2018.
  • Candriam SCA opened 79 new positions and closed 56 in Q3 2018.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $7.52B.

Based on Candriam SCA's 13F filing for Q3 2018, filed 7 Nov 2018.